Solstice Oncology is a biotech company focused on developing a next-generation anti-CTLA-4 antibody for oncology treatments, with exclusive global rights (ex-China) to the clinical-stage asset sourced from Harbour BioMed
Solstice Oncology is a biotech company focused on developing a next-generation anti-CTLA-4 antibody for oncology treatments, with exclusive global rights (ex-China) to the clinical-stage asset sourced from Harbour BioMed.